Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suryaa Manoharan

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Molecular Diversity|December 11, 2025
Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a reviewSuryaa Manoharan, Ekambaram Perumal
Bioorganic Chemistry|December 8, 2024
Chemotherapeutic potential of radotinib against blood and solid tumors: A beacon of hope in drug repurposingSuryaa Manoharan, Ekambaram Perumal
Fitoterapia|October 22, 2024
A strategic review of STAT3 signaling inhibition by phytochemicals for cancer prevention and treatment: Advances and insightsSuryaa Manoharan, Ekambaram Perumal
European Journal of Pharmacology|October 20, 2022
Potential role of Marine Bioactive Compounds in cancer signaling pathways: A reviewSuryaa Manoharan, Ekambaram Perumal
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2026
An integrative genomic analysis of angiogenesis in hepatocellular carcinoma: from canonical drivers to emerging biomarkersSuryaa Manoharan, Viswaganesh Venkatesan, Ekambaram Perumal
Fitoterapia|January 3, 2024
Natural bioactive compounds and FOXO3a in cancer therapeutics: An updateSuryaa Manoharan, Kunjkumar Prajapati, Ekambaram Perumal
Applied Biochemistry and Biotechnology|October 14, 2025
Saikosaponin D Modulates STAT3 and c-Myc Expression in MDA-MB-231 Cells: A Comprehensive In Silico and In Vitro StudyBhuvaneshwari Deivendran, Suryaa Manoharan, Ekambaram Perumal
Archiv Der Pharmazie|October 21, 2024
Targeting STAT3, FOXO3a, and Pim-1 kinase by FDA-approved tyrosine kinase inhibitor-Radotinib: An in silico and in vitro approachSuryaa Manoharan, Aksayakeerthana Santhakumar, Ekambaram Perumal
Applied Biochemistry and Biotechnology|April 5, 2023
Potent FOXO3a Activators from Biologically Active Compound Library for Cancer Therapeutics: An in silico ApproachSuryaa Manoharan, Hemamalini Vedagiri, Ekambaram Perumal
Phytotherapy Research : PTR|April 8, 2026
A Comprehensive Review on Necroptosis Inducing Phytochemicals for Cancer Therapy: Preclinical EvidenceBhuvaneshwari Deivendran, Suryaa Manoharan, Ekambaram Perumal
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Molecular Diversity|December 11, 2025
Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a reviewSuryaa Manoharan, Ekambaram Perumal
Bioorganic Chemistry|December 8, 2024
Chemotherapeutic potential of radotinib against blood and solid tumors: A beacon of hope in drug repurposingSuryaa Manoharan, Ekambaram Perumal
Fitoterapia|October 22, 2024
A strategic review of STAT3 signaling inhibition by phytochemicals for cancer prevention and treatment: Advances and insightsSuryaa Manoharan, Ekambaram Perumal
European Journal of Pharmacology|October 20, 2022
Potential role of Marine Bioactive Compounds in cancer signaling pathways: A reviewSuryaa Manoharan, Ekambaram Perumal
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2026
An integrative genomic analysis of angiogenesis in hepatocellular carcinoma: from canonical drivers to emerging biomarkersSuryaa Manoharan, Viswaganesh Venkatesan, Ekambaram Perumal
Fitoterapia|January 3, 2024
Natural bioactive compounds and FOXO3a in cancer therapeutics: An updateSuryaa Manoharan, Kunjkumar Prajapati, Ekambaram Perumal
Applied Biochemistry and Biotechnology|October 14, 2025
Saikosaponin D Modulates STAT3 and c-Myc Expression in MDA-MB-231 Cells: A Comprehensive In Silico and In Vitro StudyBhuvaneshwari Deivendran, Suryaa Manoharan, Ekambaram Perumal
Archiv Der Pharmazie|October 21, 2024
Targeting STAT3, FOXO3a, and Pim-1 kinase by FDA-approved tyrosine kinase inhibitor-Radotinib: An in silico and in vitro approachSuryaa Manoharan, Aksayakeerthana Santhakumar, Ekambaram Perumal
Applied Biochemistry and Biotechnology|April 5, 2023
Potent FOXO3a Activators from Biologically Active Compound Library for Cancer Therapeutics: An in silico ApproachSuryaa Manoharan, Hemamalini Vedagiri, Ekambaram Perumal
Phytotherapy Research : PTR|April 8, 2026
A Comprehensive Review on Necroptosis Inducing Phytochemicals for Cancer Therapy: Preclinical EvidenceBhuvaneshwari Deivendran, Suryaa Manoharan, Ekambaram Perumal
Pageof 3